![Personalis Inc](/common/images/company/N_PSNL.png)
Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT... Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. Show more
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it will release its second quarter 2024 financial results on Wednesday, August 7, 2024. In...
SALT LAKE CITY and FREMONT, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in genetic testing and precision medicine, and Personalis, Inc. (Nasdaq:...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that Chris Hall, CEO and President, will join a panel and speak at the TD Cowen 3rd Annual Tools / Dx...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it has updated the ASCO data highlights conference call to Friday, June 21, 2024 at 8:00 a.m...
Personalis will host a webinar call on June 19th, 2024 at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time to present ASCO highlights from the conference Personalis, Inc. (Nasdaq: PSNL) announced...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today the commencement of commercialization efforts by Tempus for NeXT Personal®, Personalis’...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two podium presentations and multiple posters featuring data for the company’s NeXT...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.95 | 38 | 2.5 | 4.52 | 2.5 | 5645781 | 3.67191685 | CS |
4 | 2.21 | 178.225806452 | 1.24 | 4.52 | 1.135 | 2025877 | 3.17991883 | CS |
12 | 1.83 | 112.962962963 | 1.62 | 4.52 | 1.135 | 824506 | 2.85979348 | CS |
26 | 1.96 | 131.543624161 | 1.49 | 4.52 | 1.12 | 553954 | 2.40334127 | CS |
52 | 1.31 | 61.214953271 | 2.14 | 4.52 | 0.8906 | 492584 | 1.99958543 | CS |
156 | -18.01 | -83.9235787512 | 21.46 | 23.04 | 0.8906 | 457129 | 5.36490564 | CS |
260 | -17.32 | -83.3895040924 | 20.77 | 53.46 | 0.8906 | 502870 | 13.59248944 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.